| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
NuVasive (NASDAQ:NUVA) reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
NuVasive beat estimated earnings by 9.3%, reporting an EPS of $0.47 versus an estimate of $0.43.
Revenue was up $16.95 million from the same period last year.
Last quarter the company missed on EPS by $0.08 which was followed by a 0.5% drop in the share price the next day.
Here's a look at NuVasive's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.51 | 0.54 | 0.56 | 0.39 |
| EPS Actual | 0.43 | 0.54 | 0.47 | 0.54 |
| Revenue Estimate | 311.10M | 298.75M | 306.62M | 277.97M |
| Revenue Actual | 305.45M | 295.28M | 310.45M | 290.76M |
To track all earnings releases for NuVasive visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: NUVA
